nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K1—hematopoietic system—stomach cancer	0.00828	0.0768	CbGeAlD
Trametinib—MAP2K1—epithelium—stomach cancer	0.00757	0.0702	CbGeAlD
Trametinib—MAP2K1—smooth muscle tissue—stomach cancer	0.0073	0.0677	CbGeAlD
Trametinib—MAP2K2—hematopoietic system—stomach cancer	0.00729	0.0676	CbGeAlD
Trametinib—MAP2K2—smooth muscle tissue—stomach cancer	0.00642	0.0596	CbGeAlD
Trametinib—MAP2K2—pancreas—stomach cancer	0.00594	0.0551	CbGeAlD
Trametinib—MAP2K1—lymphoid tissue—stomach cancer	0.00583	0.0541	CbGeAlD
Trametinib—MAP2K1—digestive system—stomach cancer	0.00576	0.0534	CbGeAlD
Trametinib—MAP2K1—bone marrow—stomach cancer	0.00531	0.0492	CbGeAlD
Trametinib—MAP2K2—lymphoid tissue—stomach cancer	0.00513	0.0476	CbGeAlD
Trametinib—MAP2K2—digestive system—stomach cancer	0.00507	0.047	CbGeAlD
Trametinib—MAP2K1—endocrine gland—stomach cancer	0.00476	0.0441	CbGeAlD
Trametinib—MAP2K2—bone marrow—stomach cancer	0.00467	0.0434	CbGeAlD
Trametinib—MAP2K1—liver—stomach cancer	0.00429	0.0398	CbGeAlD
Trametinib—MAP2K2—endocrine gland—stomach cancer	0.00419	0.0389	CbGeAlD
Trametinib—MAP2K2—liver—stomach cancer	0.00378	0.035	CbGeAlD
Trametinib—MAP2K1—lymph node—stomach cancer	0.00329	0.0305	CbGeAlD
Trametinib—MAP2K2—lymph node—stomach cancer	0.0029	0.0269	CbGeAlD
Trametinib—CYP2C8—hematopoietic system—stomach cancer	0.00253	0.0234	CbGeAlD
Trametinib—CYP3A4—hematopoietic system—stomach cancer	0.00171	0.0159	CbGeAlD
Trametinib—CYP2C8—endocrine gland—stomach cancer	0.00145	0.0135	CbGeAlD
Trametinib—CYP2C8—liver—stomach cancer	0.00131	0.0121	CbGeAlD
Trametinib—CYP3A4—digestive system—stomach cancer	0.00119	0.011	CbGeAlD
Trametinib—CYP3A4—endocrine gland—stomach cancer	0.000983	0.00912	CbGeAlD
Trametinib—CYP3A4—liver—stomach cancer	0.000886	0.00822	CbGeAlD
Trametinib—Vision blurred—Capecitabine—stomach cancer	0.000318	0.000794	CcSEcCtD
Trametinib—Renal failure—Methotrexate—stomach cancer	0.000316	0.000789	CcSEcCtD
Trametinib—Neutropenia—Epirubicin—stomach cancer	0.000315	0.000788	CcSEcCtD
Trametinib—Stomatitis—Methotrexate—stomach cancer	0.000313	0.000783	CcSEcCtD
Trametinib—Leukopenia—Docetaxel—stomach cancer	0.000312	0.000779	CcSEcCtD
Trametinib—Anaemia—Capecitabine—stomach cancer	0.000312	0.000779	CcSEcCtD
Trametinib—Body temperature increased—Fluorouracil—stomach cancer	0.000311	0.000778	CcSEcCtD
Trametinib—Haematuria—Methotrexate—stomach cancer	0.000306	0.000765	CcSEcCtD
Trametinib—Pancreatitis—Doxorubicin—stomach cancer	0.000306	0.000764	CcSEcCtD
Trametinib—Hyperglycaemia—Epirubicin—stomach cancer	0.000304	0.00076	CcSEcCtD
Trametinib—Cough—Docetaxel—stomach cancer	0.000304	0.00076	CcSEcCtD
Trametinib—Epistaxis—Methotrexate—stomach cancer	0.000303	0.000757	CcSEcCtD
Trametinib—Leukopenia—Capecitabine—stomach cancer	0.000302	0.000754	CcSEcCtD
Trametinib—Hypertension—Docetaxel—stomach cancer	0.000301	0.000751	CcSEcCtD
Trametinib—Infestation NOS—Epirubicin—stomach cancer	0.000301	0.000751	CcSEcCtD
Trametinib—Infestation—Epirubicin—stomach cancer	0.000301	0.000751	CcSEcCtD
Trametinib—Arthralgia—Docetaxel—stomach cancer	0.000296	0.000741	CcSEcCtD
Trametinib—Myalgia—Docetaxel—stomach cancer	0.000296	0.000741	CcSEcCtD
Trametinib—Renal failure—Epirubicin—stomach cancer	0.000295	0.000739	CcSEcCtD
Trametinib—Asthenia—Irinotecan—stomach cancer	0.000295	0.000737	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000294	0.000736	CcSEcCtD
Trametinib—Cough—Capecitabine—stomach cancer	0.000294	0.000735	CcSEcCtD
Trametinib—Stomatitis—Epirubicin—stomach cancer	0.000293	0.000732	CcSEcCtD
Trametinib—Urinary tract infection—Epirubicin—stomach cancer	0.000292	0.00073	CcSEcCtD
Trametinib—Neutropenia—Doxorubicin—stomach cancer	0.000292	0.000729	CcSEcCtD
Trametinib—Hypertension—Capecitabine—stomach cancer	0.000291	0.000728	CcSEcCtD
Trametinib—Dry mouth—Docetaxel—stomach cancer	0.00029	0.000725	CcSEcCtD
Trametinib—Haemoglobin—Methotrexate—stomach cancer	0.00029	0.000724	CcSEcCtD
Trametinib—Haemorrhage—Methotrexate—stomach cancer	0.000288	0.000721	CcSEcCtD
Trametinib—Myalgia—Capecitabine—stomach cancer	0.000287	0.000717	CcSEcCtD
Trametinib—Arthralgia—Capecitabine—stomach cancer	0.000287	0.000717	CcSEcCtD
Trametinib—Haematuria—Epirubicin—stomach cancer	0.000287	0.000716	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000285	0.000713	CcSEcCtD
Trametinib—Urinary tract disorder—Methotrexate—stomach cancer	0.000285	0.000712	CcSEcCtD
Trametinib—Oedema—Docetaxel—stomach cancer	0.000284	0.00071	CcSEcCtD
Trametinib—Epistaxis—Epirubicin—stomach cancer	0.000283	0.000709	CcSEcCtD
Trametinib—Urethral disorder—Methotrexate—stomach cancer	0.000283	0.000706	CcSEcCtD
Trametinib—Infection—Docetaxel—stomach cancer	0.000282	0.000706	CcSEcCtD
Trametinib—Hyperglycaemia—Doxorubicin—stomach cancer	0.000281	0.000703	CcSEcCtD
Trametinib—Diarrhoea—Irinotecan—stomach cancer	0.000281	0.000703	CcSEcCtD
Trametinib—Dry mouth—Capecitabine—stomach cancer	0.000281	0.000702	CcSEcCtD
Trametinib—Nervous system disorder—Docetaxel—stomach cancer	0.000279	0.000697	CcSEcCtD
Trametinib—Pruritus—Fluorouracil—stomach cancer	0.000279	0.000696	CcSEcCtD
Trametinib—Thrombocytopenia—Docetaxel—stomach cancer	0.000278	0.000696	CcSEcCtD
Trametinib—Infestation NOS—Doxorubicin—stomach cancer	0.000278	0.000695	CcSEcCtD
Trametinib—Infestation—Doxorubicin—stomach cancer	0.000278	0.000695	CcSEcCtD
Trametinib—Skin disorder—Docetaxel—stomach cancer	0.000276	0.00069	CcSEcCtD
Trametinib—Oedema—Capecitabine—stomach cancer	0.000275	0.000688	CcSEcCtD
Trametinib—Bradycardia—Epirubicin—stomach cancer	0.000275	0.000687	CcSEcCtD
Trametinib—Renal failure—Doxorubicin—stomach cancer	0.000273	0.000683	CcSEcCtD
Trametinib—Infection—Capecitabine—stomach cancer	0.000273	0.000683	CcSEcCtD
Trametinib—Dizziness—Irinotecan—stomach cancer	0.000272	0.00068	CcSEcCtD
Trametinib—Haemoglobin—Epirubicin—stomach cancer	0.000271	0.000678	CcSEcCtD
Trametinib—Stomatitis—Doxorubicin—stomach cancer	0.000271	0.000678	CcSEcCtD
Trametinib—Urinary tract infection—Doxorubicin—stomach cancer	0.00027	0.000676	CcSEcCtD
Trametinib—Nervous system disorder—Capecitabine—stomach cancer	0.00027	0.000674	CcSEcCtD
Trametinib—Haemorrhage—Epirubicin—stomach cancer	0.00027	0.000674	CcSEcCtD
Trametinib—Eye disorder—Methotrexate—stomach cancer	0.000269	0.000673	CcSEcCtD
Trametinib—Diarrhoea—Fluorouracil—stomach cancer	0.000269	0.000673	CcSEcCtD
Trametinib—Thrombocytopenia—Capecitabine—stomach cancer	0.000269	0.000673	CcSEcCtD
Trametinib—Cardiac disorder—Methotrexate—stomach cancer	0.000268	0.000669	CcSEcCtD
Trametinib—Skin disorder—Capecitabine—stomach cancer	0.000267	0.000668	CcSEcCtD
Trametinib—Urinary tract disorder—Epirubicin—stomach cancer	0.000266	0.000666	CcSEcCtD
Trametinib—Hyperhidrosis—Capecitabine—stomach cancer	0.000266	0.000665	CcSEcCtD
Trametinib—Oedema peripheral—Epirubicin—stomach cancer	0.000266	0.000664	CcSEcCtD
Trametinib—Haematuria—Doxorubicin—stomach cancer	0.000265	0.000663	CcSEcCtD
Trametinib—Connective tissue disorder—Epirubicin—stomach cancer	0.000265	0.000663	CcSEcCtD
Trametinib—Urethral disorder—Epirubicin—stomach cancer	0.000264	0.000661	CcSEcCtD
Trametinib—Epistaxis—Doxorubicin—stomach cancer	0.000262	0.000656	CcSEcCtD
Trametinib—Angiopathy—Methotrexate—stomach cancer	0.000262	0.000654	CcSEcCtD
Trametinib—Vomiting—Irinotecan—stomach cancer	0.000261	0.000653	CcSEcCtD
Trametinib—Dizziness—Fluorouracil—stomach cancer	0.00026	0.000651	CcSEcCtD
Trametinib—Mediastinal disorder—Methotrexate—stomach cancer	0.00026	0.00065	CcSEcCtD
Trametinib—Rash—Irinotecan—stomach cancer	0.000259	0.000648	CcSEcCtD
Trametinib—Dermatitis—Irinotecan—stomach cancer	0.000259	0.000647	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000259	0.000647	CcSEcCtD
Trametinib—Chills—Methotrexate—stomach cancer	0.000259	0.000647	CcSEcCtD
Trametinib—Headache—Irinotecan—stomach cancer	0.000258	0.000644	CcSEcCtD
Trametinib—Insomnia—Docetaxel—stomach cancer	0.000257	0.000643	CcSEcCtD
Trametinib—Bradycardia—Doxorubicin—stomach cancer	0.000254	0.000635	CcSEcCtD
Trametinib—Mental disorder—Methotrexate—stomach cancer	0.000253	0.000631	CcSEcCtD
Trametinib—Eye disorder—Epirubicin—stomach cancer	0.000252	0.00063	CcSEcCtD
Trametinib—Erythema—Methotrexate—stomach cancer	0.000251	0.000627	CcSEcCtD
Trametinib—Malnutrition—Methotrexate—stomach cancer	0.000251	0.000627	CcSEcCtD
Trametinib—Haemoglobin—Doxorubicin—stomach cancer	0.000251	0.000627	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000251	0.000627	CcSEcCtD
Trametinib—Cardiac disorder—Epirubicin—stomach cancer	0.00025	0.000626	CcSEcCtD
Trametinib—Vomiting—Fluorouracil—stomach cancer	0.00025	0.000626	CcSEcCtD
Trametinib—Haemorrhage—Doxorubicin—stomach cancer	0.00025	0.000624	CcSEcCtD
Trametinib—Insomnia—Capecitabine—stomach cancer	0.000249	0.000622	CcSEcCtD
Trametinib—Rash—Fluorouracil—stomach cancer	0.000248	0.000621	CcSEcCtD
Trametinib—Dermatitis—Fluorouracil—stomach cancer	0.000248	0.00062	CcSEcCtD
Trametinib—Decreased appetite—Docetaxel—stomach cancer	0.000247	0.000618	CcSEcCtD
Trametinib—Headache—Fluorouracil—stomach cancer	0.000247	0.000617	CcSEcCtD
Trametinib—Urinary tract disorder—Doxorubicin—stomach cancer	0.000247	0.000616	CcSEcCtD
Trametinib—Oedema peripheral—Doxorubicin—stomach cancer	0.000246	0.000615	CcSEcCtD
Trametinib—Dysgeusia—Methotrexate—stomach cancer	0.000246	0.000614	CcSEcCtD
Trametinib—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000245	0.000613	CcSEcCtD
Trametinib—Connective tissue disorder—Doxorubicin—stomach cancer	0.000245	0.000613	CcSEcCtD
Trametinib—Fatigue—Docetaxel—stomach cancer	0.000245	0.000612	CcSEcCtD
Trametinib—Angiopathy—Epirubicin—stomach cancer	0.000245	0.000612	CcSEcCtD
Trametinib—Urethral disorder—Doxorubicin—stomach cancer	0.000245	0.000612	CcSEcCtD
Trametinib—Nausea—Irinotecan—stomach cancer	0.000244	0.00061	CcSEcCtD
Trametinib—Mediastinal disorder—Epirubicin—stomach cancer	0.000243	0.000608	CcSEcCtD
Trametinib—Constipation—Docetaxel—stomach cancer	0.000243	0.000607	CcSEcCtD
Trametinib—Back pain—Methotrexate—stomach cancer	0.000243	0.000607	CcSEcCtD
Trametinib—Chills—Epirubicin—stomach cancer	0.000242	0.000605	CcSEcCtD
Trametinib—Arrhythmia—Epirubicin—stomach cancer	0.000241	0.000602	CcSEcCtD
Trametinib—Decreased appetite—Capecitabine—stomach cancer	0.000239	0.000598	CcSEcCtD
Trametinib—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000238	0.000594	CcSEcCtD
Trametinib—Fatigue—Capecitabine—stomach cancer	0.000237	0.000593	CcSEcCtD
Trametinib—Vision blurred—Methotrexate—stomach cancer	0.000237	0.000591	CcSEcCtD
Trametinib—Mental disorder—Epirubicin—stomach cancer	0.000236	0.000591	CcSEcCtD
Trametinib—Constipation—Capecitabine—stomach cancer	0.000235	0.000588	CcSEcCtD
Trametinib—Erythema—Epirubicin—stomach cancer	0.000235	0.000587	CcSEcCtD
Trametinib—Malnutrition—Epirubicin—stomach cancer	0.000235	0.000587	CcSEcCtD
Trametinib—Nausea—Fluorouracil—stomach cancer	0.000234	0.000585	CcSEcCtD
Trametinib—Eye disorder—Doxorubicin—stomach cancer	0.000233	0.000583	CcSEcCtD
Trametinib—Gastrointestinal pain—Docetaxel—stomach cancer	0.000232	0.000581	CcSEcCtD
Trametinib—Anaemia—Methotrexate—stomach cancer	0.000232	0.00058	CcSEcCtD
Trametinib—Cardiac disorder—Doxorubicin—stomach cancer	0.000232	0.000579	CcSEcCtD
Trametinib—Dysgeusia—Epirubicin—stomach cancer	0.00023	0.000575	CcSEcCtD
Trametinib—Back pain—Epirubicin—stomach cancer	0.000227	0.000568	CcSEcCtD
Trametinib—Angiopathy—Doxorubicin—stomach cancer	0.000226	0.000566	CcSEcCtD
Trametinib—Muscle spasms—Epirubicin—stomach cancer	0.000226	0.000564	CcSEcCtD
Trametinib—Gastrointestinal pain—Capecitabine—stomach cancer	0.000225	0.000562	CcSEcCtD
Trametinib—Mediastinal disorder—Doxorubicin—stomach cancer	0.000225	0.000562	CcSEcCtD
Trametinib—Abdominal pain—Docetaxel—stomach cancer	0.000225	0.000562	CcSEcCtD
Trametinib—Body temperature increased—Docetaxel—stomach cancer	0.000225	0.000562	CcSEcCtD
Trametinib—Leukopenia—Methotrexate—stomach cancer	0.000225	0.000562	CcSEcCtD
Trametinib—Chills—Doxorubicin—stomach cancer	0.000224	0.00056	CcSEcCtD
Trametinib—Arrhythmia—Doxorubicin—stomach cancer	0.000223	0.000557	CcSEcCtD
Trametinib—Vision blurred—Epirubicin—stomach cancer	0.000221	0.000553	CcSEcCtD
Trametinib—Cough—Methotrexate—stomach cancer	0.000219	0.000547	CcSEcCtD
Trametinib—Mental disorder—Doxorubicin—stomach cancer	0.000219	0.000547	CcSEcCtD
Trametinib—Abdominal pain—Capecitabine—stomach cancer	0.000218	0.000544	CcSEcCtD
Trametinib—Body temperature increased—Capecitabine—stomach cancer	0.000218	0.000544	CcSEcCtD
Trametinib—Erythema—Doxorubicin—stomach cancer	0.000217	0.000543	CcSEcCtD
Trametinib—Malnutrition—Doxorubicin—stomach cancer	0.000217	0.000543	CcSEcCtD
Trametinib—Anaemia—Epirubicin—stomach cancer	0.000217	0.000543	CcSEcCtD
Trametinib—Myalgia—Methotrexate—stomach cancer	0.000214	0.000534	CcSEcCtD
Trametinib—Arthralgia—Methotrexate—stomach cancer	0.000214	0.000534	CcSEcCtD
Trametinib—Dysgeusia—Doxorubicin—stomach cancer	0.000213	0.000532	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000212	0.00053	CcSEcCtD
Trametinib—Leukopenia—Epirubicin—stomach cancer	0.00021	0.000526	CcSEcCtD
Trametinib—Back pain—Doxorubicin—stomach cancer	0.00021	0.000525	CcSEcCtD
Trametinib—Muscle spasms—Doxorubicin—stomach cancer	0.000209	0.000522	CcSEcCtD
Trametinib—Cough—Epirubicin—stomach cancer	0.000205	0.000512	CcSEcCtD
Trametinib—Vision blurred—Doxorubicin—stomach cancer	0.000205	0.000512	CcSEcCtD
Trametinib—Asthenia—Docetaxel—stomach cancer	0.000204	0.00051	CcSEcCtD
Trametinib—Infection—Methotrexate—stomach cancer	0.000203	0.000509	CcSEcCtD
Trametinib—Hypertension—Epirubicin—stomach cancer	0.000203	0.000507	CcSEcCtD
Trametinib—Pruritus—Docetaxel—stomach cancer	0.000201	0.000503	CcSEcCtD
Trametinib—Nervous system disorder—Methotrexate—stomach cancer	0.000201	0.000502	CcSEcCtD
Trametinib—Anaemia—Doxorubicin—stomach cancer	0.000201	0.000502	CcSEcCtD
Trametinib—Thrombocytopenia—Methotrexate—stomach cancer	0.000201	0.000501	CcSEcCtD
Trametinib—Arthralgia—Epirubicin—stomach cancer	0.0002	0.0005	CcSEcCtD
Trametinib—Myalgia—Epirubicin—stomach cancer	0.0002	0.0005	CcSEcCtD
Trametinib—Skin disorder—Methotrexate—stomach cancer	0.000199	0.000497	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000199	0.000496	CcSEcCtD
Trametinib—Hyperhidrosis—Methotrexate—stomach cancer	0.000198	0.000495	CcSEcCtD
Trametinib—Asthenia—Capecitabine—stomach cancer	0.000197	0.000493	CcSEcCtD
Trametinib—Dry mouth—Epirubicin—stomach cancer	0.000196	0.000489	CcSEcCtD
Trametinib—Pruritus—Capecitabine—stomach cancer	0.000195	0.000487	CcSEcCtD
Trametinib—Leukopenia—Doxorubicin—stomach cancer	0.000195	0.000486	CcSEcCtD
Trametinib—Diarrhoea—Docetaxel—stomach cancer	0.000194	0.000486	CcSEcCtD
Trametinib—Oedema—Epirubicin—stomach cancer	0.000192	0.000479	CcSEcCtD
Trametinib—Infection—Epirubicin—stomach cancer	0.00019	0.000476	CcSEcCtD
Trametinib—Cough—Doxorubicin—stomach cancer	0.00019	0.000474	CcSEcCtD
Trametinib—Diarrhoea—Capecitabine—stomach cancer	0.000188	0.000471	CcSEcCtD
Trametinib—Nervous system disorder—Epirubicin—stomach cancer	0.000188	0.00047	CcSEcCtD
Trametinib—Dizziness—Docetaxel—stomach cancer	0.000188	0.00047	CcSEcCtD
Trametinib—Thrombocytopenia—Epirubicin—stomach cancer	0.000188	0.000469	CcSEcCtD
Trametinib—Hypertension—Doxorubicin—stomach cancer	0.000188	0.000469	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000187	0.000466	CcSEcCtD
Trametinib—Skin disorder—Epirubicin—stomach cancer	0.000186	0.000465	CcSEcCtD
Trametinib—Hyperhidrosis—Epirubicin—stomach cancer	0.000185	0.000463	CcSEcCtD
Trametinib—Insomnia—Methotrexate—stomach cancer	0.000185	0.000463	CcSEcCtD
Trametinib—Arthralgia—Doxorubicin—stomach cancer	0.000185	0.000462	CcSEcCtD
Trametinib—Myalgia—Doxorubicin—stomach cancer	0.000185	0.000462	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000184	0.000459	CcSEcCtD
Trametinib—Dizziness—Capecitabine—stomach cancer	0.000182	0.000455	CcSEcCtD
Trametinib—Dry mouth—Doxorubicin—stomach cancer	0.000181	0.000452	CcSEcCtD
Trametinib—Vomiting—Docetaxel—stomach cancer	0.000181	0.000452	CcSEcCtD
Trametinib—Rash—Docetaxel—stomach cancer	0.000179	0.000448	CcSEcCtD
Trametinib—Dermatitis—Docetaxel—stomach cancer	0.000179	0.000447	CcSEcCtD
Trametinib—Decreased appetite—Methotrexate—stomach cancer	0.000178	0.000445	CcSEcCtD
Trametinib—Headache—Docetaxel—stomach cancer	0.000178	0.000445	CcSEcCtD
Trametinib—Oedema—Doxorubicin—stomach cancer	0.000177	0.000443	CcSEcCtD
Trametinib—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000177	0.000442	CcSEcCtD
Trametinib—Fatigue—Methotrexate—stomach cancer	0.000177	0.000441	CcSEcCtD
Trametinib—Infection—Doxorubicin—stomach cancer	0.000176	0.00044	CcSEcCtD
Trametinib—Vomiting—Capecitabine—stomach cancer	0.000175	0.000437	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000175	0.000437	CcSEcCtD
Trametinib—Nervous system disorder—Doxorubicin—stomach cancer	0.000174	0.000435	CcSEcCtD
Trametinib—Thrombocytopenia—Doxorubicin—stomach cancer	0.000174	0.000434	CcSEcCtD
Trametinib—Rash—Capecitabine—stomach cancer	0.000173	0.000434	CcSEcCtD
Trametinib—Insomnia—Epirubicin—stomach cancer	0.000173	0.000433	CcSEcCtD
Trametinib—Dermatitis—Capecitabine—stomach cancer	0.000173	0.000433	CcSEcCtD
Trametinib—Headache—Capecitabine—stomach cancer	0.000172	0.000431	CcSEcCtD
Trametinib—Skin disorder—Doxorubicin—stomach cancer	0.000172	0.000431	CcSEcCtD
Trametinib—Hyperhidrosis—Doxorubicin—stomach cancer	0.000171	0.000429	CcSEcCtD
Trametinib—Nausea—Docetaxel—stomach cancer	0.000169	0.000422	CcSEcCtD
Trametinib—Gastrointestinal pain—Methotrexate—stomach cancer	0.000167	0.000419	CcSEcCtD
Trametinib—Decreased appetite—Epirubicin—stomach cancer	0.000167	0.000417	CcSEcCtD
Trametinib—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000165	0.000414	CcSEcCtD
Trametinib—Fatigue—Epirubicin—stomach cancer	0.000165	0.000413	CcSEcCtD
Trametinib—Constipation—Epirubicin—stomach cancer	0.000164	0.00041	CcSEcCtD
Trametinib—Nausea—Capecitabine—stomach cancer	0.000163	0.000409	CcSEcCtD
Trametinib—Abdominal pain—Methotrexate—stomach cancer	0.000162	0.000405	CcSEcCtD
Trametinib—Body temperature increased—Methotrexate—stomach cancer	0.000162	0.000405	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000162	0.000404	CcSEcCtD
Trametinib—Insomnia—Doxorubicin—stomach cancer	0.00016	0.000401	CcSEcCtD
Trametinib—Gastrointestinal pain—Epirubicin—stomach cancer	0.000157	0.000392	CcSEcCtD
Trametinib—Decreased appetite—Doxorubicin—stomach cancer	0.000154	0.000385	CcSEcCtD
Trametinib—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000153	0.000383	CcSEcCtD
Trametinib—Fatigue—Doxorubicin—stomach cancer	0.000153	0.000382	CcSEcCtD
Trametinib—Constipation—Doxorubicin—stomach cancer	0.000152	0.000379	CcSEcCtD
Trametinib—Body temperature increased—Epirubicin—stomach cancer	0.000152	0.000379	CcSEcCtD
Trametinib—Abdominal pain—Epirubicin—stomach cancer	0.000152	0.000379	CcSEcCtD
Trametinib—Asthenia—Methotrexate—stomach cancer	0.000147	0.000367	CcSEcCtD
Trametinib—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000145	0.000363	CcSEcCtD
Trametinib—Pruritus—Methotrexate—stomach cancer	0.000145	0.000362	CcSEcCtD
Trametinib—Abdominal pain—Doxorubicin—stomach cancer	0.00014	0.00035	CcSEcCtD
Trametinib—Body temperature increased—Doxorubicin—stomach cancer	0.00014	0.00035	CcSEcCtD
Trametinib—Diarrhoea—Methotrexate—stomach cancer	0.00014	0.00035	CcSEcCtD
Trametinib—Asthenia—Epirubicin—stomach cancer	0.000138	0.000344	CcSEcCtD
Trametinib—Pruritus—Epirubicin—stomach cancer	0.000136	0.000339	CcSEcCtD
Trametinib—Dizziness—Methotrexate—stomach cancer	0.000135	0.000339	CcSEcCtD
Trametinib—Diarrhoea—Epirubicin—stomach cancer	0.000131	0.000328	CcSEcCtD
Trametinib—Vomiting—Methotrexate—stomach cancer	0.00013	0.000326	CcSEcCtD
Trametinib—Rash—Methotrexate—stomach cancer	0.000129	0.000323	CcSEcCtD
Trametinib—Dermatitis—Methotrexate—stomach cancer	0.000129	0.000323	CcSEcCtD
Trametinib—Headache—Methotrexate—stomach cancer	0.000128	0.000321	CcSEcCtD
Trametinib—Asthenia—Doxorubicin—stomach cancer	0.000127	0.000318	CcSEcCtD
Trametinib—Dizziness—Epirubicin—stomach cancer	0.000127	0.000317	CcSEcCtD
Trametinib—Pruritus—Doxorubicin—stomach cancer	0.000125	0.000314	CcSEcCtD
Trametinib—Vomiting—Epirubicin—stomach cancer	0.000122	0.000305	CcSEcCtD
Trametinib—Nausea—Methotrexate—stomach cancer	0.000122	0.000304	CcSEcCtD
Trametinib—Diarrhoea—Doxorubicin—stomach cancer	0.000121	0.000303	CcSEcCtD
Trametinib—Rash—Epirubicin—stomach cancer	0.000121	0.000302	CcSEcCtD
Trametinib—Dermatitis—Epirubicin—stomach cancer	0.000121	0.000302	CcSEcCtD
Trametinib—Headache—Epirubicin—stomach cancer	0.00012	0.0003	CcSEcCtD
Trametinib—Dizziness—Doxorubicin—stomach cancer	0.000117	0.000293	CcSEcCtD
Trametinib—Nausea—Epirubicin—stomach cancer	0.000114	0.000285	CcSEcCtD
Trametinib—Vomiting—Doxorubicin—stomach cancer	0.000113	0.000282	CcSEcCtD
Trametinib—Rash—Doxorubicin—stomach cancer	0.000112	0.00028	CcSEcCtD
Trametinib—Dermatitis—Doxorubicin—stomach cancer	0.000112	0.000279	CcSEcCtD
Trametinib—Headache—Doxorubicin—stomach cancer	0.000111	0.000278	CcSEcCtD
Trametinib—Nausea—Doxorubicin—stomach cancer	0.000105	0.000263	CcSEcCtD
Trametinib—CYP3A4—Metabolism—BLVRB—stomach cancer	2.18e-05	4.42e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PGLS—stomach cancer	2.18e-05	4.42e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MAPK3—stomach cancer	2.17e-05	4.42e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PPP2R1A—stomach cancer	2.16e-05	4.39e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6ST—stomach cancer	2.15e-05	4.37e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALDOB—stomach cancer	2.13e-05	4.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6R—stomach cancer	2.13e-05	4.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CAV1—stomach cancer	2.12e-05	4.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOA1—stomach cancer	2.12e-05	4.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—stomach cancer	2.09e-05	4.24e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CASP8—stomach cancer	2.09e-05	4.24e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6R—stomach cancer	2.08e-05	4.22e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.08e-05	4.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—KRAS—stomach cancer	2.07e-05	4.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MAPK1—stomach cancer	2.07e-05	4.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EGFR—stomach cancer	2.07e-05	4.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APC—stomach cancer	2.07e-05	4.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADRB2—stomach cancer	2.07e-05	4.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDH1—stomach cancer	2.06e-05	4.19e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—RHOA—stomach cancer	2.06e-05	4.18e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MAPK3—stomach cancer	2.03e-05	4.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PPP2R1A—stomach cancer	2.02e-05	4.11e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6ST—stomach cancer	2.01e-05	4.09e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.01e-05	4.08e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SMAD4—stomach cancer	2.01e-05	4.08e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2e-05	4.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALOX5—stomach cancer	1.98e-05	4.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—KRAS—stomach cancer	1.95e-05	3.97e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CASP8—stomach cancer	1.95e-05	3.96e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DPYD—stomach cancer	1.95e-05	3.96e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6R—stomach cancer	1.95e-05	3.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MAPK1—stomach cancer	1.94e-05	3.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EGFR—stomach cancer	1.94e-05	3.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APC—stomach cancer	1.93e-05	3.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDH1—stomach cancer	1.93e-05	3.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—RHOA—stomach cancer	1.92e-05	3.91e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6R—stomach cancer	1.92e-05	3.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FYN—stomach cancer	1.91e-05	3.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HRAS—stomach cancer	1.88e-05	3.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SMAD4—stomach cancer	1.88e-05	3.82e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA1—stomach cancer	1.85e-05	3.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.85e-05	3.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FBP1—stomach cancer	1.85e-05	3.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CKB—stomach cancer	1.85e-05	3.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—KRAS—stomach cancer	1.83e-05	3.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CXCL8—stomach cancer	1.8e-05	3.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—stomach cancer	1.8e-05	3.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SERPINE1—stomach cancer	1.8e-05	3.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6R—stomach cancer	1.8e-05	3.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PIK3CA—stomach cancer	1.8e-05	3.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGFR2—stomach cancer	1.79e-05	3.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FYN—stomach cancer	1.78e-05	3.62e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.77e-05	3.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HRAS—stomach cancer	1.76e-05	3.58e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLIN2—stomach cancer	1.74e-05	3.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB2—stomach cancer	1.74e-05	3.53e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—RHOA—stomach cancer	1.73e-05	3.52e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTT1—stomach cancer	1.72e-05	3.5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—stomach cancer	1.72e-05	3.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2A6—stomach cancer	1.7e-05	3.46e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA2—stomach cancer	1.69e-05	3.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL8—stomach cancer	1.69e-05	3.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—stomach cancer	1.68e-05	3.42e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SERPINE1—stomach cancer	1.68e-05	3.42e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PIK3CA—stomach cancer	1.68e-05	3.41e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGFR2—stomach cancer	1.67e-05	3.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—HRAS—stomach cancer	1.66e-05	3.38e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKR1C3—stomach cancer	1.66e-05	3.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NT5E—stomach cancer	1.65e-05	3.35e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PGAM1—stomach cancer	1.65e-05	3.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS2—stomach cancer	1.64e-05	3.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB2—stomach cancer	1.63e-05	3.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RHOA—stomach cancer	1.62e-05	3.3e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ENO1—stomach cancer	1.61e-05	3.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1B—stomach cancer	1.61e-05	3.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—stomach cancer	1.61e-05	3.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB2—stomach cancer	1.61e-05	3.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—stomach cancer	1.59e-05	3.23e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CAV1—stomach cancer	1.59e-05	3.23e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.59e-05	3.23e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOA1—stomach cancer	1.59e-05	3.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—stomach cancer	1.58e-05	3.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.57e-05	3.2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLCE1—stomach cancer	1.57e-05	3.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—stomach cancer	1.57e-05	3.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—HRAS—stomach cancer	1.55e-05	3.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS2—stomach cancer	1.53e-05	3.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—JUN—stomach cancer	1.53e-05	3.11e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCB—stomach cancer	1.51e-05	3.07e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UMPS—stomach cancer	1.51e-05	3.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6ST—stomach cancer	1.51e-05	3.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1B—stomach cancer	1.51e-05	3.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB2—stomach cancer	1.5e-05	3.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—stomach cancer	1.49e-05	3.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CAV1—stomach cancer	1.49e-05	3.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1B—stomach cancer	1.49e-05	3.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1A—stomach cancer	1.49e-05	3.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOA1—stomach cancer	1.48e-05	3.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—stomach cancer	1.48e-05	3.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—stomach cancer	1.47e-05	2.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK8—stomach cancer	1.45e-05	2.95e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APC—stomach cancer	1.45e-05	2.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—JUN—stomach cancer	1.43e-05	2.91e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD44—stomach cancer	1.43e-05	2.91e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCB—stomach cancer	1.42e-05	2.88e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6ST—stomach cancer	1.41e-05	2.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PDHA1—stomach cancer	1.4e-05	2.85e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ECHS1—stomach cancer	1.4e-05	2.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1B—stomach cancer	1.39e-05	2.83e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1A—stomach cancer	1.39e-05	2.82e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.39e-05	2.82e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—MAPK3—stomach cancer	1.39e-05	2.82e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1A—stomach cancer	1.37e-05	2.79e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK8—stomach cancer	1.36e-05	2.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APC—stomach cancer	1.35e-05	2.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6R—stomach cancer	1.34e-05	2.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—STAT3—stomach cancer	1.33e-05	2.69e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—MAPK1—stomach cancer	1.32e-05	2.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TYMP—stomach cancer	1.32e-05	2.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FADS1—stomach cancer	1.32e-05	2.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EGFR—stomach cancer	1.32e-05	2.68e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—MAPK3—stomach cancer	1.3e-05	2.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1A—stomach cancer	1.28e-05	2.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK3—stomach cancer	1.27e-05	2.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—stomach cancer	1.26e-05	2.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6R—stomach cancer	1.26e-05	2.56e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—KRAS—stomach cancer	1.25e-05	2.53e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—STAT3—stomach cancer	1.24e-05	2.52e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SREBF2—stomach cancer	1.24e-05	2.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—MAPK1—stomach cancer	1.23e-05	2.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EGFR—stomach cancer	1.23e-05	2.51e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—STAT3—stomach cancer	1.22e-05	2.49e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—RORA—stomach cancer	1.22e-05	2.48e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPP2R1A—stomach cancer	1.22e-05	2.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RHOA—stomach cancer	1.21e-05	2.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK1—stomach cancer	1.21e-05	2.45e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EGFR—stomach cancer	1.21e-05	2.45e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—stomach cancer	1.2e-05	2.44e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTP1—stomach cancer	1.19e-05	2.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK3—stomach cancer	1.19e-05	2.41e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—stomach cancer	1.18e-05	2.39e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—stomach cancer	1.18e-05	2.39e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MAPK3—stomach cancer	1.17e-05	2.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—KRAS—stomach cancer	1.17e-05	2.37e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—STAT3—stomach cancer	1.15e-05	2.33e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PIK3CA—stomach cancer	1.14e-05	2.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDOB—stomach cancer	1.14e-05	2.32e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—KRAS—stomach cancer	1.14e-05	2.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MYC—stomach cancer	1.14e-05	2.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RHOA—stomach cancer	1.14e-05	2.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK1—stomach cancer	1.13e-05	2.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EGFR—stomach cancer	1.13e-05	2.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—stomach cancer	1.12e-05	2.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB2—stomach cancer	1.12e-05	2.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MAPK1—stomach cancer	1.11e-05	2.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EGFR—stomach cancer	1.11e-05	2.26e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TYMS—stomach cancer	1.11e-05	2.26e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—stomach cancer	1.1e-05	2.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAPK3—stomach cancer	1.09e-05	2.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PIK3CA—stomach cancer	1.07e-05	2.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL8—stomach cancer	1.07e-05	2.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—KRAS—stomach cancer	1.07e-05	2.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MYC—stomach cancer	1.06e-05	2.16e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALOX5—stomach cancer	1.06e-05	2.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HRAS—stomach cancer	1.06e-05	2.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB2—stomach cancer	1.05e-05	2.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—KRAS—stomach cancer	1.05e-05	2.14e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DPYD—stomach cancer	1.05e-05	2.13e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PIK3CA—stomach cancer	1.05e-05	2.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAPK1—stomach cancer	1.04e-05	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1B—stomach cancer	1.04e-05	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EGFR—stomach cancer	1.04e-05	2.12e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ERCC2—stomach cancer	1.03e-05	2.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—stomach cancer	1.01e-05	2.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL8—stomach cancer	9.97e-06	2.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCND1—stomach cancer	9.93e-06	2.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JUN—stomach cancer	9.91e-06	2.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HRAS—stomach cancer	9.91e-06	2.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—KRAS—stomach cancer	9.83e-06	2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PIK3CA—stomach cancer	9.79e-06	1.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1B—stomach cancer	9.74e-06	1.98e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—stomach cancer	9.7e-06	1.97e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HRAS—stomach cancer	9.68e-06	1.97e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PIK3CA—stomach cancer	9.66e-06	1.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—stomach cancer	9.64e-06	1.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1A—stomach cancer	9.61e-06	1.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—stomach cancer	9.48e-06	1.93e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK8—stomach cancer	9.38e-06	1.91e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCND1—stomach cancer	9.29e-06	1.89e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JUN—stomach cancer	9.27e-06	1.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—stomach cancer	9.26e-06	1.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTT1—stomach cancer	9.25e-06	1.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2A6—stomach cancer	9.14e-06	1.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HRAS—stomach cancer	9.05e-06	1.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PIK3CA—stomach cancer	9.03e-06	1.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—stomach cancer	9.02e-06	1.83e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1A—stomach cancer	8.99e-06	1.83e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAV1—stomach cancer	8.95e-06	1.82e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HRAS—stomach cancer	8.93e-06	1.82e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA1—stomach cancer	8.93e-06	1.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKR1C3—stomach cancer	8.9e-06	1.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK8—stomach cancer	8.77e-06	1.78e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ENO1—stomach cancer	8.67e-06	1.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—stomach cancer	8.67e-06	1.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—stomach cancer	8.66e-06	1.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—STAT3—stomach cancer	8.57e-06	1.74e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—stomach cancer	8.55e-06	1.74e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.55e-06	1.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HRAS—stomach cancer	8.36e-06	1.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK3—stomach cancer	8.19e-06	1.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—stomach cancer	8.1e-06	1.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—STAT3—stomach cancer	8.02e-06	1.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—stomach cancer	8e-06	1.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MYC—stomach cancer	7.97e-06	1.62e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—stomach cancer	7.87e-06	1.6e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK1—stomach cancer	7.79e-06	1.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EGFR—stomach cancer	7.79e-06	1.58e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD44—stomach cancer	7.69e-06	1.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK3—stomach cancer	7.66e-06	1.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MYC—stomach cancer	7.45e-06	1.51e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KRAS—stomach cancer	7.36e-06	1.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK1—stomach cancer	7.29e-06	1.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EGFR—stomach cancer	7.29e-06	1.48e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—stomach cancer	7.07e-06	1.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KRAS—stomach cancer	6.89e-06	1.4e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—stomach cancer	6.77e-06	1.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CA—stomach cancer	6.76e-06	1.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—stomach cancer	6.54e-06	1.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6.54e-06	1.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTP1—stomach cancer	6.41e-06	1.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CA—stomach cancer	6.33e-06	1.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—stomach cancer	6.32e-06	1.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HRAS—stomach cancer	6.26e-06	1.27e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—stomach cancer	6.19e-06	1.26e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—stomach cancer	6.12e-06	1.24e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—stomach cancer	5.99e-06	1.22e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TYMS—stomach cancer	5.96e-06	1.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—stomach cancer	5.89e-06	1.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HRAS—stomach cancer	5.85e-06	1.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—stomach cancer	5.6e-06	1.14e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ERCC2—stomach cancer	5.54e-06	1.13e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—stomach cancer	5.21e-06	1.06e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAV1—stomach cancer	4.8e-06	9.76e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA1—stomach cancer	4.79e-06	9.74e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—stomach cancer	4.22e-06	8.58e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CA—stomach cancer	3.81e-06	7.74e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—stomach cancer	3.8e-06	7.72e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—stomach cancer	3.63e-06	7.38e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—stomach cancer	3.32e-06	6.75e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.04e-06	4.15e-06	CbGpPWpGaD
